Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$164.19

-5.55 (-3.27%)

10:05
06/14/18
06/14
10:05
06/14/18
10:05

Sage drops 3% after inking Asian market collaboration

Shares of Sage Therapeutics are moving lower after the company last night announced a strategic collaboration with Shionogi & Co. for the clinical development and commercialization of SAGE-217 for the treatment of major depressive disorder and other indications in Japan, Taiwan and South Korea. Under the terms of the agreement, Shionogi will be responsible for all clinical development, regulatory filings and commercialization of SAGE-217 for MDD, and potentially other indications, in Japan, Taiwan and South Korea. Shionogi will make an upfront payment to Sage of $90M, and Sage will be eligible to receive additional development and commercial milestones of up to $485M. Sage will receive tiered royalties on sales of SAGE-217 in Japan, Taiwan and South Korea, if development efforts are successful, with tiers averaging in the greater than 20% range. Shares of Sage are down 3% to $164.84 in early trading. Investors may be wondering if the deal pushes out the timeline of a potential takeover, EP Vantage said on Twitter. The firm, though, views the $90M upfront as "impressive" given the region and thinks Sage's takeout thesis "remains intact." Reference Link

SAGE Sage Therapeutics
$164.19

-5.55 (-3.27%)

05/03/18
BMOC
05/03/18
NO CHANGE
Target $203
BMOC
Outperform
Sage Therapeutics pipeline programs on track, says BMO Capital
BMO Capital analyst Gary Nachman is pleased with the progress Sage Therapeutics is making building out its commercial infrastructure and preparing for a successful launch of brexanolone. All the company's other pipeline programs remain on track, Nachman tells investors in a post-earnings research note. The analyst remains optimistic in approval with a "very favorable risk/benefit profile." He is an aggressive buyer of Sage shares at current levels and reiterates an Outperform rating on the name with a $203 price target.
06/06/18
LTCO
06/06/18
INITIATION
Target $230
LTCO
Buy
Sage Therapeutics initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Michael Higgins started Sage Therapeutics with a Buy rating and $230 price target.
06/13/18
ADAM
06/13/18
NO CHANGE
Target $220
ADAM
Buy
Sage Therapeutics price target raised to $220 from $210 at Canaccord
Canaccord analyst Sumant Kulkarni raised his price target on Sage Therapeutics to $220 from $210 after the company announced it had a positive breakthrough meeting with the FDA on Sage-217, an oral drug being developed for postpartum depression, major depressive disorder and other psychiatric indications. Kulkarni believes the MDD indication is the main stock driver and he views the developments as very encouraging. Kulkarni reiterated his Buy rating on Sage shares.
06/13/18
JEFF
06/13/18
NO CHANGE
Target $9
JEFF
Buy
Sage update yesterday positive for Xenon, says Jefferies
Jefferies analyst Maury Raycroft believes Sage Therapeutics' (SAGE) FDA approval to accelerate a development path for '217 in major depressive disorder and postpartum depression provides a positive read-through for Xenon Pharmaceuticals (XENE). Xenon has two epilepsy programs and one program for hemiplegic migraine, which all have potential in rare disease indications with broader applicability, Raycroft tells investors in a research note. He believes "recent derisking" provides a "great entry point" into Xenon Pharmaceuticals at current share levels. The analyst has a Buy rating on the shares with a $9 price target.

TODAY'S FREE FLY STORIES

ABT

Abbott

$72.00

0.57 (0.80%)

14:50
09/25/18
09/25
14:50
09/25/18
14:50
Hot Stocks
Abbott says study shows Portico safely reduced severe aortic stenosis »

Abbott announced one-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

NKE

Nike

$85.02

0.75 (0.89%)

14:49
09/25/18
09/25
14:49
09/25/18
14:49
Options
Nike options imply 8.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EZPW

Ezcorp

$10.58

0.075 (0.71%)

14:45
09/25/18
09/25
14:45
09/25/18
14:45
Conference/Events
Ezcorp management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 06

    Nov

CNDT

Conduent

$22.30

0.12 (0.54%)

14:37
09/25/18
09/25
14:37
09/25/18
14:37
Conference/Events
Conduent management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

INTC

Intel

$46.14

-0.77 (-1.64%)

, ADI

Analog Devices

$92.82

-2.19 (-2.31%)

14:36
09/25/18
09/25
14:36
09/25/18
14:36
Hot Stocks
Intel slides as analyst says sell with semis seen in cyclical downturn »

Shares of Intel (INTC)…

INTC

Intel

$46.14

-0.77 (-1.64%)

ADI

Analog Devices

$92.82

-2.19 (-2.31%)

MCHP

Microchip

$79.10

-3.19 (-3.88%)

ON

ON Semiconductor

$18.44

-0.665 (-3.48%)

MPWR

Monolithic Power

$129.88

-2.99 (-2.25%)

AMD

AMD

$32.59

-0.03 (-0.09%)

NVDA

Nvidia

$268.05

2.33 (0.88%)

QCOM

Qualcomm

$73.16

-0.43 (-0.58%)

SIMO

Silicon Motion

$54.13

-0.04 (-0.07%)

MXIM

Maxim Integrated

$58.13

-1.61 (-2.70%)

TXN

Texas Instruments

$107.78

-2.03 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 04

    Oct

  • 08

    Oct

  • 22

    Oct

  • 10

    Dec

  • 08

    May

BRC

Brady

$44.20

0.15 (0.34%)

14:35
09/25/18
09/25
14:35
09/25/18
14:35
Hot Stocks
Brady director Elizabeth Bruno sells over $1M in company stock »

Brady director Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$67.05

(0.00%)

, GBNK

Guaranty Bancorp

$29.95

(0.00%)

14:25
09/25/18
09/25
14:25
09/25/18
14:25
Conference/Events
Guaranty Bancorp to host special shareholder meeting »

Special Shareholder…

IBTX

Independent Bank

$67.05

(0.00%)

GBNK

Guaranty Bancorp

$29.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

14:20
09/25/18
09/25
14:20
09/25/18
14:20
General news
FOMC began its 2-day meeting and will announce its decision at 14 ET Wednesday »

FOMC began its 2-day…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

, AAPL

Apple

$222.01

1.22 (0.55%)

14:19
09/25/18
09/25
14:19
09/25/18
14:19
Hot Stocks
Salesforce Co-CEO Benioff says 'economy is still ripping' »

Marc Benioff is being…

CRM

Salesforce

$158.62

-0.235 (-0.15%)

AAPL

Apple

$222.01

1.22 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/25/18
09/25
14:17
09/25/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/25/18
09/25
14:16
09/25/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$3.47

0.175 (5.31%)

14:10
09/25/18
09/25
14:10
09/25/18
14:10
Options
5-strike call buyers in Antares Pharma and implied volatility spikes »

5-strike call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

FB

Facebook

$165.12

-0.285 (-0.17%)

14:06
09/25/18
09/25
14:06
09/25/18
14:06
Periodicals
Facebook likely to pick Adam Mosseri to head Instagram, The Information says »

Facebook will likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

PAYX

Paychex

$73.06

-1.5 (-2.01%)

, ADP

ADP

$147.62

-1.5 (-1.01%)

14:04
09/25/18
09/25
14:04
09/25/18
14:04
Recommendations
Paychex, ADP, Square analyst commentary  »

New Square payroll app…

PAYX

Paychex

$73.06

-1.5 (-2.01%)

ADP

ADP

$147.62

-1.5 (-1.01%)

SQ

Square

$94.22

8.16 (9.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 11

    Oct

  • 22

    Oct

  • 31

    Oct

  • 26

    Nov

NTES

NetEase

$214.55

4.41 (2.10%)

14:00
09/25/18
09/25
14:00
09/25/18
14:00
Upgrade
NetEase rating change  »

Follow-up: NetEase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$147.41

-1.71 (-1.15%)

13:55
09/25/18
09/25
13:55
09/25/18
13:55
Options
ADP put volume heavy and directionally bearish »

Bearish flow noted in ADP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

GTS

Triple-S

$20.33

-0.7 (-3.33%)

13:50
09/25/18
09/25
13:50
09/25/18
13:50
Hot Stocks
Triple-S finalizes contract with Government of Puerto Rico on Medicaid plan »

Triple-S Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

NTES

NetEase

$214.61

4.47 (2.13%)

13:47
09/25/18
09/25
13:47
09/25/18
13:47
Upgrade
NetEase rating change  »

NetEase upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.29

5.41 (3.06%)

, GOOG

Alphabet

$1,184.00

10.62 (0.91%)

13:46
09/25/18
09/25
13:46
09/25/18
13:46
Periodicals
Spotify asks EU for stronger regulations against U.S. rivals, Reuters reports »

Driven by concerns over…

SPOT

Spotify

$182.29

5.41 (3.06%)

GOOG

Alphabet

$1,184.00

10.62 (0.91%)

GOOGL

Alphabet Class A

$1,192.91

13.13 (1.11%)

AMZN

Amazon.com

$1,957.44

22.94 (1.19%)

EBAY

eBay

$32.72

-1 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

HIMX

Himax

$5.87

-0.03 (-0.51%)

13:45
09/25/18
09/25
13:45
09/25/18
13:45
Options
Himax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
09/25/18
09/25
13:45
09/25/18
13:45
General news
FOMC Forecast revisions »

FOMC Forecast revisions…

SHOP

Shopify

$163.33

1.06 (0.65%)

, AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

13:43
09/25/18
09/25
13:43
09/25/18
13:43
Periodicals
Shopify CEO welcomes competition from Amazon, Bloomberg reports »

Shopify's (SHOP) CEO…

SHOP

Shopify

$163.33

1.06 (0.65%)

AMZN

Amazon.com

$1,957.00

22.5 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 13

    Nov

CHRS

Coherus Biosciences

$16.35

0.3 (1.87%)

13:40
09/25/18
09/25
13:40
09/25/18
13:40
Hot Stocks
Coherus Biosciences receives European Commission approval for UDENYCA »

Coherus BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Nov

LMT

Lockheed Martin

$344.92

7.27 (2.15%)

13:36
09/25/18
09/25
13:36
09/25/18
13:36
Hot Stocks
U.S. Army awards Lockheed Martin $289M HIMARS contract »

The U.S. Army awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

KMX

CarMax

$76.31

0.43 (0.57%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.